Previous close | 3.5000 |
Open | 3.4900 |
Bid | 3.2100 x 800 |
Ask | 3.3000 x 3000 |
Day's range | 3.2300 - 3.5000 |
52-week range | 0.3710 - 5.5800 |
Volume | |
Avg. volume | 437,485 |
Market cap | 93.153M |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2800 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.88 |
BOSTON, March 28, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors.
Director Thomas Kirk has recently increased his stake in Myomo Inc (AMEX:MYO) by purchasing 50,000 shares of the company's stock, as indicated by a SEC Filing dated March 14, 2024.
Myomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call Transcript March 7, 2024 Myomo, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Myomo Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode. […]